Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Novel Dihydrothiopyrano[4,3-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles
Zhao Wang, Waleed A. Zalloum, Wenbo Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13658-13675
Open Access | Times Cited: 20

Showing 20 citing articles:

Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
Shujing Xu, Dang Ding, Xujie Zhang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 850-850
Open Access | Times Cited: 25
Recent developments of pyrimidine appended HIV-1 non-nucleoside reverse transcriptase inhibitors
S. Maheen Abdul Rahman, Gurpreet Singh, Md. Sakirul Islam Khan, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108273-108273
Closed Access
Discovery of Novel Pyridine-Dimethyl-Phenyl-DAPY Hybrids by Molecular Fusing of Methyl-Pyrimidine-DAPYs and Difluoro-Pyridinyl-DAPYs: Improving the Druggability toward High Inhibitory Activity, Solubility, Safety, and PK
Li Ding, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2122-2138
Open Access | Times Cited: 16
Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability
Ya-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 3054-3066
Open Access | Times Cited: 9
Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Human Immunodeficiency Virus-1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like Profiles
Zhao Wang, Prem P. Sharma, Brijesh Rathi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8643-8665
Closed Access | Times Cited: 9
Development of Novel Dihydrofuro[3,4-d]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C
Dongwei Kang, Yanying Sun, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2458-2470
Open Access | Times Cited: 13
One-pot synthesis of 4-pyrimidone-2-thioether through base/acid-mediated condensation of S-alkylisothiourea and β-ketoester
Zhichao Lu, Tsung-Yun Wong, Yonghong Gan, et al.
RSC Advances (2024) Vol. 14, Iss. 8, pp. 5435-5439
Open Access | Times Cited: 2
Discovery of novel diarypyrimidine derivatives bearing six-membered non-aromatic heterocycles as potent HIV-1 NNRTIs with improved anti-resistance and drug-like profiles
Xiangyi Jiang, Boshi Huang, Waleed A. Zalloum, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115605-115605
Closed Access | Times Cited: 6
Design and Characterization of a Natural Arf-GEFs Inhibitor Prodrug CHNQD-01255 with Potent Anti-Hepatocellular Carcinoma Efficacy In Vivo
Yao-Yao Jiang, Yang Gao, Jianyu Liu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 11970-11984
Closed Access | Times Cited: 10
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Murugesan Vanangamudi, Palaniappan Senthilkumar, M. K. Kathiravan, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1992-1992
Open Access | Times Cited: 5
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
Zhao Wang, Heng Zhang, Zhen Gao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1257-1282
Open Access | Times Cited: 5
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019-2023)
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators
Shuo Wang, Yujie Ren, Qilan Li, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106192-106192
Open Access | Times Cited: 7
Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present)
Cui Deng, Heng Yan, Jun Wang, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 12, pp. 104378-104378
Open Access | Times Cited: 6
Adagrasib’s Second-Generation Synthesis: Transitioning from Route Scouting to Optimization
Zhichao Lu, Chengsheng Chen, Dinesh J. Paymode, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3128-3142
Open Access
Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles
Zhao Wang, Wenbo Wang, Zhen Gao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access
Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies
Shang Li, Xinxin Li, Liangliang Ma, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 23, pp. 21049-21069
Closed Access
A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
Jiwei Zhang, Chuanfeng Liu, Ruifang Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Diarylpyrimidines and related analogs as antiviral agents
Shuang‐Xi Gu, Jiong Chen, Yuan‐Yuan Zhu, et al.
Elsevier eBooks (2023), pp. 513-542
Closed Access
Page 1

Scroll to top